Australia - English - Department of Health (Therapeutic Goods Administration)

specialised therapeutics alim pty ltd - tafasitamab, quantity: 200 mg - injection, powder for - excipient ingredients: polysorbate 20; citric acid monohydrate; trehalose dihydrate; sodium citrate dihydrate - minjuvi is indicated in combination with lenalidomide followed by minjuvi monotherapy for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) who are not eligible for autologous stem cell transplant (asct).,this indication was approved via the provisional approval pathway, based on objective response rate and duration of response in a single arm trial. continued approval for this indication depends on verification and description of clinical benefit in a confirmatory trial.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - tretinoin, quantity: 0.25 mg; clindamycin phosphate, quantity: 12 mg (equivalent: clindamycin, qty 10 mg) - gel - excipient ingredients: purified water; disodium edetate; methyl hydroxybenzoate; carbomer 981; butylated hydroxytoluene; polysorbate 80; citric acid; glycerol; propyl hydroxybenzoate; trometamol - acnatac is indicated for the topical treatment of acne vulgaris when comedones, papules and pustules are present in patients 12 years or older. consideration should be given to official guidance on the appropriate use of antibacterial agents and acne treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - folic acid, quantity: 5 mg/ml - injection - excipient ingredients: water for injections; sodium hydroxide; disodium edetate - 1. megaloblastic anaemia where the anaemia has been proven to be due to folate deficiency only. 2. prevention of folic acid deficiency in pregnancy and lactation.

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - folic acid, quantity: 15 mg/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; disodium edetate - 1. megaloblastic anaemia where the anaemia has been proven to be due to folate deficiency only. 2. prevention of folic acid deficiency in pregnancy and lactation.

Australia - English - Department of Health (Therapeutic Goods Administration)

besins healthcare australia pty ltd - drospirenone, quantity: 4 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; povidone; colloidal anhydrous silica; magnesium stearate; hypromellose; triacetin; polysorbate 80; titanium dioxide; indigo carmine aluminium lake; iron oxide yellow - contraception

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - letermovir, quantity: 480 mg - tablet, film coated - excipient ingredients: povidone; croscarmellose sodium; magnesium stearate; silicon dioxide; microcrystalline cellulose; carnauba wax; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow; iron oxide red - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - letermovir, quantity: 480 mg - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections; sodium chloride; hydroxypropylbetadex - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - letermovir, quantity: 240 mg - tablet, film coated - excipient ingredients: carnauba wax; croscarmellose sodium; magnesium stearate; silicon dioxide; microcrystalline cellulose; povidone; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - letermovir, quantity: 240 mg - injection, concentrated - excipient ingredients: water for injections; hydroxypropylbetadex; sodium chloride; sodium hydroxide - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - meloxicam, quantity: 15 mg - tablet, uncoated - excipient ingredients: maize starch; magnesium stearate; colloidal anhydrous silica; lactose monohydrate; pregelatinised maize starch; sodium citrate dihydrate; microcrystalline cellulose - symptomatic treatment of osteoarthritis and rheumatoid arthritis.